Independent research and analysis on EBC-46 (tigilanol tiglate) and Blushwood berry extract. Covering peer-reviewed science, clinical trials, and the latest developments in this emerging field.

Dropper Measurement Variability in Blushwood Berry Tinctures: What EBC-46 Users Report About Dosing Consistency

How much actual liquid a glass dropper delivers per squeeze varies — what blushwood berry tincture users report about measurement consistency and practical workarounds.

Phorbol Ester Biosynthesis in Fontainea picrosperma: How the Blushwood Tree Makes Tigilanol Tiglate

What is known about the biosynthetic pathway producing tigilanol tiglate and related daphnane esters in Fontainea picrosperma seed, and why the plant likely makes these compounds.

Geographic Distribution of Tigilanol Tiglate (EBC-46) Clinical Trial Sites: Where the Human Research Is Actually Happening

A look at where tigilanol tiglate human clinical trials have been conducted to date and what the geographic footprint tells us about EBC-46 translational research priorities.

ER Stress and the Unfolded Protein Response: How EBC-46 Engages PERK, IRE1α and ATF6 in Tumour Cell Death

How tigilanol tiglate intersects with endoplasmic reticulum stress and the unfolded protein response — PERK, IRE1α and ATF6 — and what published evidence shows about the EBC-46 cell-death cascade.

Mexico COFEPRIS and Herbal Remedies: How EBC-46 Botanical Supplements Are Classified

How Mexico's COFEPRIS classifies herbal remedies (remedios herbolarios) and dietary supplements (suplementos alimenticios), and what this means for EBC-46 blushwood berry products.

First-Open Headspace and Post-Opening Oxidation of Blushwood Berry Tinctures: User Reports on Bottle Life After Seal Break

What users report about how blushwood berry tincture stability changes after the first opening, and how headspace oxygen, light, and refrigeration interact during normal use.

Water Relations and Drought Tolerance in Fontainea picrosperma: Hydraulic Constraints on Blushwood Cultivation

How leaf-level water potential, stomatal regulation, and xylem hydraulics shape the cultivation envelope for Fontainea picrosperma, the blushwood berry tree behind EBC-46.

Circulating Tumour DNA (ctDNA) as a Pharmacodynamic Biomarker in Tigilanol Tiglate (EBC-46) Clinical Trials

How ctDNA / liquid biopsy is emerging as a dynamic biomarker for monitoring early response, residual disease, and recurrence in tigilanol tiglate (EBC-46) clinical trials.

Heat Shock Protein Response and EBC-46: How Tigilanol Tiglate Engages HSP70 and HSP90 Chaperone Networks

How the cellular stress response system — including HSP70 and HSP90 chaperones — interacts with tigilanol tiglate (EBC-46) signalling, and what this means for tumour cell death cascades.

China's NMPA Health Food (保健食品) Framework: How EBC-46 Botanical Supplements Would Be Classified

How China's NMPA classifies imported botanicals under the Health Food (Bao Jian Shi Pin) framework and what this means for EBC-46 supplements seeking market entry.

Carrier Solvent in Blushwood Berry Tinctures: What Users Report About Ethanol and Glycerin Bases

What EBC-46 supplement users report about the carrier base of blushwood berry tinctures — ethanol vs. glycerin formulations, taste, extraction completeness, and storage trade-offs.

Cold Tolerance and Frost Sensitivity in Fontainea picrosperma: Climate Constraints on Blushwood Cultivation

How temperature regimes shape the cultivation envelope for Fontainea picrosperma — the blushwood berry tree that produces EBC-46 (tigilanol tiglate) — and what controlled-environment growers need to know.